Image

PROSPECTIVE MULTI-CENTER EVALUATION OF THE DURATION OF THERAPY FOR THROMBOSIS IN CHILDREN (the "Kids-DOTT" Trial)

Studying Treatment Time for Blood Clots in Children

Recruiting
20 years and younger
All

This study investigates the best treatment duration for children with blood clots in the veins. Blood clots can block veins, which are blood vessels that carry blood back to the heart. The study aims to find out how long children should be treated to balance the risk of bleeding against the risk of the clot forming again.

Participants will have follow-up scans of their clots, which are part of their regular care, to help decide the treatment length. The study will also look at how different blood thinning medicines might affect long-term outcomes. The type of blood thinner each child receives will be chosen by their doctor.

  • Who can participate: Children from birth to under 21 years old with a blood clot in a vein confirmed by a scan can participate. The clot must have occurred in the past 30 days and be caused by a specific event, like surgery or infection.
  • Study details: Participants will have follow-up scans of their clots to help determine how long they need to take blood thinners. The type of blood thinner will be decided by their doctor, not the study.
Study details
    Thrombosis

TX10201

19 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.